Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis
Rev. bras. oftalmol; 80 (4), 2021
ABSTRACT Objective To assess the economic impact of reducing glaucoma progression by using the trabecular micro-bypass implant, iStent inject®, in the Reference Centers for glaucoma treatment within the Brazilian Public Unified Health System (SUS). Methods In a cost-effectiveness analysis, a Markov ...